home / stock / hook / hook news

HOOK News and Press, HOOKIPA Pharma Inc. From 07/12/19

Stock Information
Company Name: HOOKIPA Pharma Inc.
Stock Symbol: HOOK
Market: NASDAQ
Website: hookipapharma.com
Menu
HOOK HOOK Quote HOOK Short HOOK News HOOK Articles HOOK Message Board
Get HOOK Alerts

News, Short Squeeze, Breakout and More Instantly...
HOOK - ILMN, UUUU among midday movers

Gainers : Tower International (NYSE: TOWR )  +69% . Camber Energy (NYSEMKT: CEI ) +50% . HOOKIPA Pharma (NASDAQ: HOOK ) +28% . Milacron Holdings  (NYSE: MCRN ) +25% . VivoPower International PLC (NASDAQ: VVPR ) +21% . ProQR Therapeutics N.V. (NASDAQ: PRQR ) +21% . Oasmi...
HOOK - RDHL, SFIX among premarket gainers

Medigus (NASDAQ: MDGS ) +49%  on large order for visualization device. More news on: Medigus Ltd., VivoPower International PLC, HOOKIPA Pharma Inc., Stocks on the move, Read more ...

HOOK - HOOKIPA Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers

New York and VIENNA, Austria, July 11, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that its Investigational New Dru...

HOOK - GME and PVTL among midday losers

Gainers:  ReWalk Robotics (NASDAQ: RWLK ) +126% . Genocea Biosciences (NASDAQ: GNCA ) +14% . Dean Foods (NYSE: DF ) +13% . RAVE Restaurant Group (NASDAQ: RAVE ) +11% . Medley Management (NYSE: MDLY ) +10% . Neon Therapeutics (NASDAQ: NTGN ) +10% . Allena Pharmaceuticals (NASDAQ:...
HOOK - HOOKIPA Pharma misses by $8.00, beats on revenue

HOOKIPA Pharma (NASDAQ: HOOK ): Q1 GAAP EPS of -$9.27 misses by $8.00 . More news on: HOOKIPA Pharma Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

HOOK - HOOKIPA Pharma Reports First Quarter 2019 Financial Results and Recent Business Highlights

NEW YORK and VIENNA, Austria, May 20, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (“HOOKIPA”), a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform, today reported recent business highli...

HOOK - HOOKIPA Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead

NEW YORK and VIENNA, Austria, May 08, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that it has achieved a further re...
Previous 10 Next 10